Ophthalmic Education:
Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist: Appendix 1: Ischemic Optic Neuropathy Decompression Trial (IONDT)
More on Ophthalmic Education:
Educational Resources:
ICO Educational Programs:
- Overview of ICO Education
- Resident and Specialist Education
- Ophthalmic Continuing Education
- ICO Continuing Education Requirements
- Medical Student Education
- Allied Ophthalmic Personnel Training
- International Congress of Ophthalmology
- ICO Basic and Clinical Assessments
- IFOS/ICO International Fellowship
- ICO International Clinical Guidelines
On this page:
Recommended Reading
(No authors listed). Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA 1995; 273: 625-632
Newman NJ, Scherer R, Langenberg P et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002; 134: 317-328
Additional Background Reading
(No authors listed). The ischemic optic neuropathy decompression trial (IONDT): design and methods. Control Clin Trials 1998; 19: 276-296
(No authors listed). Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996; 114: 1366-1374
(No authors listed). Ischemic Optic Neuropathy Decompression Trial: twenty-four-month update. Arch Ophthalmol 2000; 118: 793-798
Next: Appendix 1: Retina - Studies of the Ocular Complications of AIDS (SOCA)
Also see: Table of Contents of the Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist
You are here: Home > Ophthalmic Education > Resident and Specialist Education > Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist> Appendix 1: Ischemic Optic Neuropathy Decompression Trial (IONDT)